Recent RNAi Collaborations of Note

Oct 17, 2003

Premium

File Attachments

RNALab101703.gif

Filed under

Gene Silencing/Gene Editing

RNAi

Breaking News

Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic
Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies
Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection
23andMe Team Sees Genetic, Nongenetic Contributors to COVID-19 Risk in Trans-Ancestry Study
Todos Medical Acquires Provista Diagnostics for $7.5M
Renalytix AI Lands US Government Contract for Kidney Disease Test

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.